Literature DB >> 1332735

Diversity of human p53 mutants revealed by complex formation to SV40 T antigen.

J Bártek1, B Vojtĕsek, D P Lane.   

Abstract

The products of the two major suppressor genes p53 and Rb interact with the oncogene products of the DNA tumour viruses. These viral-host protein interactions mimic and interfere with the normal interactions of p53 and Rb with host proteins. The Rb gene product is frequently mutated in human cancers such that it no longer binds to viral or host proteins. In contrast we find that this is not the case with p53 as some, but not all, mutant p53 proteins still bind to the SV40 T antigen. In particular the hot spot mutation found in most Chinese and African cases of hepatocellular carcinoma (HCC) retains T binding activity. The simple subdivision of different p53 mutations revealed by this analysis may have diagnostic and prognostic consequences.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332735     DOI: 10.1016/0959-8049(93)90584-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2.

Authors:  J Nylandsted; M Rohde; K Brand; L Bastholm; F Elling; M Jäättelä
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3.

Authors:  X W Wang; K Forrester; H Yeh; M A Feitelson; J R Gu; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

3.  Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

Authors:  K Ory; Y Legros; C Auguin; T Soussi
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

4.  DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.

Authors:  J Lukas; H Müller; J Bartkova; D Spitkovsky; A A Kjerulff; P Jansen-Dürr; M Strauss; J Bartek
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

5.  Defective interleukin six expression and responsiveness in human mammary cells transformed by an adeno 5/SV40 hybrid virus.

Authors:  F Basolo; L Fiore; S Calvo; V Falcone; P G Conaldi; G Fontanini; A M Caligo; G Merlo; Y Gluzman; A Toniolo
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.